BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23102107)

  • 21. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
    Swartz MJ; Batra SK; Varshney GC; Hollingsworth MA; Yeo CJ; Cameron JL; Wilentz RE; Hruban RH; Argani P
    Am J Clin Pathol; 2002 May; 117(5):791-6. PubMed ID: 12090430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
    Ganguly K; Cox JL; Ghersi D; Grandgenett PM; Hollingsworth MA; Jain M; Kumar S; Batra SK
    Gastroenterology; 2022 Jun; 162(7):2032-2046.e12. PubMed ID: 35219699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of mucin carbohydrate antigens (T, Tn and sialyl Tn) and MUC-1 gene product in intraductal papillary-mucinous neoplasm of the pancreas.
    Terada T; Nakanuma Y
    Am J Clin Pathol; 1996 May; 105(5):613-20. PubMed ID: 8623771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
    Zhang Y; Zoltan M; Riquelme E; Xu H; Sahin I; Castro-Pando S; Montiel MF; Chang K; Jiang Z; Ling J; Gupta S; Horne W; Pruski M; Wang H; Sun SC; Lozano G; Chiao P; Maitra A; Leach SD; Kolls JK; Vilar E; Wang TC; Bailey JM; McAllister F
    Gastroenterology; 2018 Jul; 155(1):210-223.e3. PubMed ID: 29604293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
    Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
    Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin expression profile in pancreatic cancer and the precursor lesions.
    Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
    J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.
    Moniaux N; Andrianifahanana M; Brand RE; Batra SK
    Br J Cancer; 2004 Nov; 91(9):1633-8. PubMed ID: 15494719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancreatic Cancer.
    Yazawa K; Nakamura F; Masukawa D; Sato S; Hiroshima Y; Yabushita Y; Mori R; Matsuyama R; Kato I; Taniguchi H; Goshima Y; Endo I
    Transl Oncol; 2020 Mar; 13(3):100746. PubMed ID: 32105991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
    Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
    J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice.
    Quilbe A; Mustapha R; Duchêne B; Kumar A; Werkmeister E; Leteurtre E; Moralès O; Jonckheere N; Van Seuningen I; Delhem N
    Front Immunol; 2023; 14():1267279. PubMed ID: 38098486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.
    Carrara S; Cangi MG; Arcidiacono PG; Perri F; Petrone MC; Mezzi G; Boemo C; Talarico A; Cin ED; Grassini G; Doglioni C; Testoni PA
    Am J Gastroenterol; 2011 Jul; 106(7):1359-63. PubMed ID: 21647207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutively active Akt1 cooperates with KRas(G12D) to accelerate in vivo pancreatic tumor onset and progression.
    Albury TM; Pandey V; Gitto SB; Dominguez L; Spinel LP; Talarchek J; Klein-Szanto AJ; Testa JR; Altomare DA
    Neoplasia; 2015 Feb; 17(2):175-82. PubMed ID: 25748236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues.
    Balagué C; Audié JP; Porchet N; Real FX
    Gastroenterology; 1995 Sep; 109(3):953-64. PubMed ID: 7657125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.